Bespoke Extracts Inc BSPK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.11
- Day Range
- $0.11–0.11
- 52-Week Range
- $0.02–1.00
- Bid/Ask
- $0.03 / $0.90
- Market Cap
- $1.12 Mil
- Volume/Avg
- 5,001 / 6,314
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.42
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 5
- Website
- https://bespokeextracts.com
Valuation
|
Metric
|
BSPK
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.42 |
Price/Cash Flow | — |
Price/Earnings
BSPK
Financial Strength
|
Metric
|
BSPK
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.08 |
Interest Coverage | −135.48 |
Quick Ratio
BSPK
Profitability
|
Metric
|
BSPK
|
|---|---|
Return on Assets (Normalized) | −265.16% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BSPK
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vnsfvydrr | Hzvggld | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Brkvftdhk | Kxfyj | $68.9 Bil | |
HLN
| Haleon PLC ADR | Svvtgqq | Frhw | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yqvsfjqgr | Ndfng | $14.7 Bil | |
VTRS
| Viatris Inc | Xmqvvxd | Jycj | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ycfzjymlk | Jym | $11.9 Bil | |
CTLT
| Catalent Inc | Pmlxnxw | Yhptk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tdztkhy | Hqgm | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Fdkpztzmv | Ytl | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dwfhjkj | Cksrqw | $3.5 Bil |